Alberto Fragasso

794 total citations
19 papers, 321 citations indexed

About

Alberto Fragasso is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology. According to data from OpenAlex, Alberto Fragasso has authored 19 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 10 papers in Genetics and 9 papers in Hematology. Recurrent topics in Alberto Fragasso's work include Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Acute Myeloid Leukemia Research (4 papers). Alberto Fragasso is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Acute Myeloid Leukemia Research (4 papers). Alberto Fragasso collaborates with scholars based in Italy, United States and Ukraine. Alberto Fragasso's co-authors include Angela Ciancio, Caterina Stelitano, Luigi Marcheselli, Massimo Federico, Francesco Merli, Stefano Luminari, Luca Baldini, Giuseppe Rossi, Alessandra Tucci and Caterina Mammi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Genes Chromosomes and Cancer.

In The Last Decade

Alberto Fragasso

19 papers receiving 317 citations

Peers

Alberto Fragasso
Jelena Jelicic Serbia
Francesca Palombi Italy
Lilj Uziel Italy
Vlatko Pejša Croatia
L. Heimans Netherlands
P. Brice France
A. Franke Germany
Claire Hemmaway United Kingdom
Tobias Terzer Germany
Ming‐Chih Chang Taiwan
Jelena Jelicic Serbia
Alberto Fragasso
Citations per year, relative to Alberto Fragasso Alberto Fragasso (= 1×) peers Jelena Jelicic

Countries citing papers authored by Alberto Fragasso

Since Specialization
Citations

This map shows the geographic impact of Alberto Fragasso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Fragasso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Fragasso more than expected).

Fields of papers citing papers by Alberto Fragasso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Fragasso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Fragasso. The network helps show where Alberto Fragasso may publish in the future.

Co-authorship network of co-authors of Alberto Fragasso

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Fragasso. A scholar is included among the top collaborators of Alberto Fragasso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Fragasso. Alberto Fragasso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bari, Alessia, Raffaella Marcheselli, Luigi Marcheselli, et al.. (2016). A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up. Acta Haematologica. 137(1). 7–14. 2 indexed citations
2.
Iannitto, Emilio, Stefano Luminari, Claudio Tripodo, et al.. (2015). Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study. Leukemia & lymphoma. 56(12). 3281–3287. 15 indexed citations
3.
Trino, Stefania, Luciana De Luca, Vittorio Simeon, et al.. (2015). Inverse regulation of bridging integrator 1 and BCR-ABL1 in chronic myeloid leukemia. Tumor Biology. 37(1). 217–225. 2 indexed citations
4.
Voso, Maria Teresa, Pasquale Niscola, Alfonso Piciocchi, et al.. (2015). Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real‐world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia. European Journal Of Haematology. 96(4). 344–351. 26 indexed citations
5.
Maurillo, Luca, Massimo Breccia, Francesco Buccisano, et al.. (2015). Deferasirox chelation therapy in patients with transfusion‐dependent MDS: a ‘real‐world’ report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata. European Journal Of Haematology. 95(1). 52–56. 21 indexed citations
6.
Delforge, Michel, Leonard Minuk, Jean‐Claude Eisenmann, et al.. (2014). Health-related quality of life (HRQOL) in transplant-ineligible patients (pts) with newly diagnosed multiple myeloma (NDMM): Results from the first trial.. Journal of Clinical Oncology. 32(15_suppl). 8516–8516. 3 indexed citations
7.
Fragasso, Alberto, et al.. (2014). Peripheral blood hemophagocytosis in an unusual lymphoma. Clinical Case Reports. 3(1). 11–13. 1 indexed citations
8.
Merli, Francesco, Stefano Luminari, Giuseppe Rossi, et al.. (2013). Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi. Leukemia & lymphoma. 55(1). 38–43. 56 indexed citations
9.
Fragasso, Alberto, et al.. (2012). Holotranscobalamin Is a Useful Marker of Vitamin B12 Deficiency in Alcoholics. The Scientific World JOURNAL. 2012. 1–4. 9 indexed citations
10.
Sacchi, Stefano, Raffaella Marcheselli, Antonio Lazzaro, et al.. (2011). A randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplant. Leukemia & lymphoma. 52(10). 1942–1948. 23 indexed citations
11.
Fabris, Sonia, Oronzo Scarciolla, Fortunato Morabito, et al.. (2011). Multiplex ligation‐dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in Chronic lymphocytic leukemia: A comparative study. Genes Chromosomes and Cancer. 50(9). 726–734. 16 indexed citations
12.
13.
Fragasso, Alberto, et al.. (2010). Functional vitamin B12 deficiency in alcoholics: An intriguing finding in a retrospective study of megaloblastic anemic patients. European Journal of Internal Medicine. 21(2). 97–100. 25 indexed citations
14.
Fragasso, Alberto, Angela Ciancio, Carlo Gaudiano, et al.. (2010). Myocardial iron overload assessed by magnetic resonance imaging (MRI)T2* in multi-transfused patients with thalassemia and acquired anemias. European Journal of Internal Medicine. 22(1). 62–65. 33 indexed citations
15.
16.
Sacchi, Stefano, Raffaella Marcheselli, Alessia Bari, et al.. (2010). Phase II Study of Velcade® Plus Mabthera® In Relapsed Follicular Lymphomas. Blood. 116(21). 1801–1801. 1 indexed citations
17.
Capalbo, Silvana, Vincenzo Callea, Caterina Musolino, et al.. (2004). Familial B-Cell Chronic Lymphocytic Leukemia in a Population of Patients from Southern Italy. International Journal of Hematology. 79(4). 354–357. 6 indexed citations
18.
Fragasso, Alberto, et al.. (2002). Response to erythropoietin and moxifloxacin in a patient with myelodysplastic syndrome non-respondent to erythropoietin alone. European Journal of Internal Medicine. 13(8). 521–523. 1 indexed citations
19.
Catalano, Lucio, S. Improta, Michelino De Laurentiis, et al.. (1996). Prognosis of chronic myelomonocytic leukemia.. PubMed. 81(4). 324–9. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jelena Jelicic Breakdown of academic impact, for papers by Francesca Palombi Breakdown of academic impact, for papers by Lilj Uziel Breakdown of academic impact, for papers by Vlatko Pejša Breakdown of academic impact, for papers by L. Heimans Breakdown of academic impact, for papers by P. Brice Breakdown of academic impact, for papers by A. Franke Breakdown of academic impact, for papers by Claire Hemmaway Breakdown of academic impact, for papers by Tobias Terzer Breakdown of academic impact, for papers by Ming‐Chih Chang
Rankless by CCL
2026